< Back to companies

Fermion is a small molecule AI Biotech company that has entered the clinical verification stage. The self-developed Drug Studio AI drug discovery platform has been industrialized and built into an integrated AI drug research and development solution. Focusing on early innovative targets in the fields of central nervous system (CNS) and autoimmunity to develop differentiated BIC/FIC products, more than ten small molecule drug pipelines focusing on ultra-high selectivity and tissue targeting have been developed.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2015
Website
www.fulmz.com/

Categories

AI drug discoveryBiotechDrug Discovery/DevelopmentClinical Development
Only accessible to MedStartr community members. Join now

What do you think of Fermion (费米子科技)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now